Study Set: PCOL CHAPTER 8

are recently approved

antagonists that have greater selectivity for M 3

receptors than oxybutynin or trospium.

Darifenacin and solifenacin

Click To Flip the Card

Comments:

PCOL CHAPTER 8

navigate_before navigate_next